Illumina, Inc.

Illumina's goal is to apply innovative technologies and
revolutionary assays to the analysis of genetic variation and function, making
studies possible that were not even imaginable just a few years ago. Illumina’s
innovative, array-based solutions for DNA, RNA, and protein analysis serve as
tools for disease research, drug development, and the development of molecular
tests in the clinic.

Further Information: http://www.illumina.com/